A randomized, placebo-controlled trial of varenicline, a selective α4β2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers

✍ Scribed by Shih-Tzu Tsai; Hong-Jun Cho; Huey-Shinn Cheng; Cheol-Hwan Kim; Kuang-Chieh Hsueh; Clare B. Billing Jr.; Kathryn E. Williams

• Book ID: 116371994
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 229 KB
• Volume: 29
• Category: Article
• ISSN: 0149-2918
• DOI: 10.1016/j.clinthera.2007.06.011